Pharmacogenomics: Overview of Applications and Relation to Infusion Therapy.

David F Kisor David R Bright Chelsea R Manion Thomas R Smith

J Infus Nurs

Manchester University College of Pharmacy, Fort Wayne, Indiana (Drs Kisor and Smith); Ferris State University, Big Rapids, Michigan (Dr Bright); and Cedarville University, Cedarville, Ohio (Dr Manion). David F. Kisor, PharmD, BS, is the chair of pharmaceutical sciences at Manchester University College of Pharmacy. His focus is on the fields of pharmacokinetics-related pharmacogenomics. He has more than 40 publications, including a textbook on pharmacogenetics, and he has served as the chair of the pharmacogenomics special interest group of the American Association of Colleges of Pharmacy. David R. Bright, PharmD, BS, is an associate professor of pharmacy practice at Ferris State University. His focus is on community and ambulatory care pharmacy practice. He has emphasized the incorporation of pharmacogenomics into medication therapy management and collaborative drug therapy management, where he works to evaluate implementation models in the community and in transition-of-care settings. Chelsea R. Manion, PharmD, practices in oncology, inpatient, and infusion-center settings, as well as among underserved populations. Her focus in oncology care is on symptom management, patient education, and interdisciplinary health care collaboration. She is an assistant professor of pharmacy practice at Cedarville University in Cedarville, Ohio. Thomas R. Smith, PharmD, is trained in psychiatry and neurology. He currently focuses his efforts in the inpatient psychiatry setting on therapeutics and patient education. He has included pharmacogenomic data in drug therapy management, focusing on clinical applications. Dr. Smith is an assistant professor of pharmacy practice at Manchester University College of Pharmacy, Fort Wayne, Indiana.

Published: March 2017

Pharmacogenomics (PGx) describes the relationship between an individual's genes and his or her response to drug therapy. Data are accumulating that indicate that PGx has application in the clinical setting for drugs across therapeutic categories, including drugs that are administered intravenously and are of greater familiarity to infusion nurses. This article provides an overview of the science and presents common examples of PGx as it relates to drug and/or drug dose selection. Additionally, there are brief summaries of the role infusion nurses can play relative to toxicity monitoring, patient education, and other aspects of PGx.

Download full-text PDF	Source
http://dx.doi.org/10.1097/NAN.0000000000000163	DOI Listing

Publication Analysis

Top Keywords

infusion nurses

pharmacogenomics overview

overview applications

applications relation

relation infusion

infusion therapy

therapy pharmacogenomics

pgx

pharmacogenomics pgx

pgx describes

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!